Medscape

Clinical Presentations and Treatment Implications of Asthma

About 7% of Americans have asthma, and population prevalence estimates are as high as 18% in some countries. [1] Given its burden to global health, significant resources have been devoted to studying ...
Business Wire

Gossamer Bio Announces Data Presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting 2019

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease ...
Drexel University

Chronic social stressors and susceptibility to short-term variation in urban ozone: A case-crossover analysis of childhood asthma exacerbations in NYC

Growing evidence suggests that chronic social stressors (e.g., poverty, violence exposures) may modify associations between chronic air pollution exposures and health. Relatively few studies, however, ...
Seeking Alpha

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper is a clinical-stage biotechnology company focused on developing briquilimab as a therapeutic for chronic mast cell diseases. Briquilimab is a targeted aglycosylated monoclonal antibody that ...
Business Insider

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...